FierceBiotech

Epia Neuro launches with BCI device to help stroke patients rework brain signals

Epia Neuro is the latest medtech startup looking to tap the potential of brain-computer interface (BCI) technology, launching with a device that aims to turn brain signals into digital commands. The ...
Morningstar

Triple Hair Doses First Patient in Phase III Clinical Trial in Canada for Male Androgenic Alopecia

Triple Hair Group Inc. (“ Triple Hair ” or the “ Company ”), a company specializing in the development of innovative treatments for androgenic alopecia (pattern baldness), today announced that the ...
AOL

What to know about new ‘triple-G’ drug that’s helped patients lose a quarter of their body weight

The new "triple-G" drug from Eli Lilly treats both diabetes and weight loss -- but its efficacy concerns some doctors. G whiz! The latest experimental GLP-1 from Eli Lilly isn’t just a diabetes drug — ...
WCVB Channel 5 Boston

Tufts neuro-oncologist develops digital art therapy to help brain tumor patients

FORM OF A VERY SPECIAL APP. IF I TOUCH THIS AND THIS, I DON’T FEEL ANYTHING ON THIS SIDE AT ALL. SO THERE’S NO SENSATION. SANDHYA JEJURIKAR HAS NO FEELING ON THE LEFT SIDE OF HER FACE AND NO HEARING ...
MLive

Saginaw patients will no longer need to travel to Detroit for this specialized neurological care: 4 takeaways

SAGINAW, MI — This report details a new clinical affiliation between Covenant HealthCare and Henry Ford Health, set to launch on April 1. The partnership aims to significantly enhance neurological ...
Frontiers

Review: spinal shock, crossed extensor reflex, and mass reflex in dogs and cats—a literature review, clinical observations and considerations

The neurological examination of veterinary patients is paramount to determine (A) whether there is a neurological disorder, (B) what part of the nervous system is involved (neuroanatomical ...
TCTMD

Triple Agonist Appears Promising for Patients With Severe Hypertriglyceridemia

NEW ORLEANS, LA—DR10624, an investigational drug designed to reduce triglycerides among patients with severely high levels, performed well in a phase II trial, researchers announced today at the ...
EurekAlert!

ADC improves outcomes for patients with advanced triple-negative breast cancer who are ineligible for immune checkpoint inhibitors

BERLIN October 19, 2025 – Patients with an aggressive form of breast cancer who are not candidates for immune checkpoint inhibitor therapy showed significantly improved progression-free survival when ...
Medscape

Energy Drinks May Raise Suicide Risk: What to Ask Your Patients

A meta-analysis of more than 1.5 million participants has suggested that coffee and energy drinks have opposing effects on suicide risk. High coffee consumption — more than 60 cups per month — was ...
Seeking Alpha

Alzamend Neuro Announces Dosing of First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital

Topline data expected by year end Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and brain/brain-structure ...
Benzinga.com

AstraZeneca's Triple-Combination Therapy Breztri Hits Primary Goals In Two Pivotal Studies For Asthma

On Friday, AstraZeneca Plc (NASDAQ:AZN) reported topline data from Phase 3 KALOS and LOGOS trials in patients with uncontrolled asthma. KALOS and LOGOS trials ...